VA
LH icon

Vident Advisory’s Labcorp LH Stock Holding History

Vident Advisory’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.5M Buy
41,118
+12,021
+41% +$3.16M 0.08% 220
2026
Q1 		$7.76M Buy
29,097
+7,136
+32% +$1.93M 0.07% 251
2025
Q4 		$5.51M Buy
21,961
+4,232
+24% +$1.12M 0.05% 304
2025
Q3 		$5.09M Buy
17,729
+5,081
+40% +$1.36M 0.05% 305
2025
Q2 		$3.32M Buy
12,648
+10,427
+469% +$2.54M 0.04% 369
2025
Q1 		$517K Buy
2,221
+744
+50% +$181K 0.01% 1015
2024
Q4 		$339K Sell
1,477
-4
-0.3% -$918 0.01% 1126
2024
Q3 		$331K Sell
1,481
-15,859
-91% -$3.49M 0.01% 1100
2024
Q2 		$3.53M Buy
17,340
+16,179
+1,394% +$3.29M 0.1% 214
2024
Q1 		$254K Buy
1,161
+59
+5% +$13K 0.01% 1108
2023
Q4 		$250K Sell
1,102
-47,426
-98% -$9.96M 0.01% 1099
2023
Q3 		$9.76M Buy
+48,528
New +$10.2M 0.3% 99

Other funds holding LH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vident Advisory's LH Position: Q2 2026 in Review

Vident Advisory increased its Labcorp (LH) stake by 41% in Q2 2026, buying an estimated $3.16M and bringing the position to 41,118 shares worth $11.5M. The position accounts for 0.08% of the portfolio, ranked #220.

Vident Advisory first reported a position in LH in Q3 2023 and has held it in 12 quarters since. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Vident Advisory held 41,118 shares of Labcorp worth $11.5M as of Q2 2026.
  • Vident Advisory bought 12,021 Labcorp shares in Q2 2026, an estimated $3.16M.
  • Labcorp made up 0.08% of Vident Advisory's portfolio in Q2 2026, its #220 holding.
  • Vident Advisory first reported a position in Labcorp in Q3 2023 and has held it in 12 quarters since.
  • 1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.